Torrent Pharmaceuticals, 500420, TORNTPHARM Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,22,591.71
61.23
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,25,038.34
0.88%
15.06

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

5.62
7.55
6.18

EBITDA CAGR (%)

10 Years
5 Years
3 Years

3.10
8.36
5.58

PAT CAGR (%)

10 Years
5 Years
3 Years

0.98
8.83
15.35

P:E (Median)

8 Years
5 Years
3 Years

51.65
56.25
60.33

P:BV (Average)

8 Years
5 Years
3 Years

8.75
10.33
11.85

EV:EBITDA (Average)

8 Years
5 Years
3 Years

21.66
24.15
26.62

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS 48.94 56.47 73.5 89.06
P/E Ratio 74.03 64.16 49.29 40.68
Revenue 10562 11317 12965 14533
EBITDA 3368 3721 4290 4911
Net Income 1656 1911 2487 3010
ROA 11 12.7 17.8 19.6
P/B Ratio 17.96 16.15 13.56 11.27
ROE 25.38 26.46 29.63 30.09
FCFF 2475 1732 2940 3151
FCFF Yield 2.26 1.58 2.68 2.87
Net Debt 3059 2511 1287 23
BVPS 201.77 224.3 267.11 321.53

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 2,616.00 2,438.00 7.30% 2,433.00 2,143.00 13.53% 2,377.00 2,123.00 11.96% 2,434.00 2,146.00 13.42%
Expenses 1,637.00 1,539.00 6.37% 1,565.00 1,427.00 9.67% 1,490.00 1,422.00 4.78% 1,513.00 1,410.00 7.30%
EBITDA 979.00 899.00 8.90% 868.00 716.00 21.23% 887.00 701.00 26.53% 921.00 736.00 25.14%
EBIDTM 37.42% 36.87% 35.68% 33.41% 37.32% 33.02% 37.84% 34.30%
Other Income -5.00 21.00 - 15.00 76.00 -80.26% 3.00 -11.00 - -7.00 15.00 -
Interest 45.00 64.00 -29.69% 47.00 67.00 -29.85% 48.00 69.00 -30.43% 54.00 77.00 -29.87%
Depreciation 187.00 189.00 -1.06% 190.00 195.00 -2.56% 191.00 191.00 0.00% 190.00 192.00 -1.04%
PBT 742.00 667.00 11.24% 622.00 530.00 17.36% 651.00 430.00 51.40% 670.00 482.00 39.00%
Tax 191.00 198.00 -3.54% 148.00 120.00 23.33% 166.00 133.00 24.81% 210.00 155.00 35.48%
PAT 551.00 469.00 17.48% 474.00 410.00 15.61% 485.00 297.00 63.30% 460.00 327.00 40.67%
PATM 21.06% 19.24% 19.48% 19.13% 20.40% 13.99% 18.90% 15.24%
EPS 16.28 13.86 17.46% 14.01 12.12 15.59% 14.33 8.78 63.21% 13.59 9.66 40.68%

Description Jun 25 Jun 24 Var% Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var%
Net Sales 3,178.00 2,859.00 11.16% 2,959.00 2,745.00 7.80% 2,809.00 2,732.00 2.82% 2,889.00 2,660.00 8.61%
Expenses 2,146.00 1,955.00 9.77% 1,995.00 1,862.00 7.14% 1,895.00 1,863.00 1.72% 1,950.00 1,835.00 6.27%
EBITDA 1,032.00 904.00 14.16% 964.00 883.00 9.17% 914.00 869.00 5.18% 939.00 825.00 13.82%
EBIDTM 32.47% 31.62% 32.58% 32.17% 32.54% 31.81% 32.50% 31.02%
Other Income -37.00 24.00 - -18.00 31.00 - 33.00 -33.00 - -16.00 26.00 -
Interest 56.00 75.00 -25.33% 56.00 80.00 -30.00% 57.00 80.00 -28.75% 64.00 91.00 -29.67%
Depreciation 201.00 197.00 2.03% 201.00 203.00 -0.99% 199.00 213.00 -6.57% 198.00 201.00 -1.49%
PBT 738.00 656.00 12.50% 665.00 631.00 5.39% 691.00 631.00 9.51% 661.00 559.00 18.25%
Tax 190.00 199.00 -4.52% 167.00 182.00 -8.24% 188.00 188.00 0.00% 208.00 173.00 20.23%
PAT 548.00 457.00 19.91% 498.00 449.00 10.91% 503.00 443.00 13.54% 453.00 386.00 17.36%
PATM 17.24% 15.98% 16.83% 16.36% 17.91% 16.22% 15.68% 14.51%
EPS 16.19 13.50 19.93% 14.71 13.27 10.85% 14.86 13.09 13.52% 13.38 11.40 17.37%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 9,860.00 9,682.44 8,532.90 7,695.20 6,742.32 6,450.57 6,168.44 5,762.48 4,244.43 4,551.45 5,419.59 Net Sales Growth 11.41% 13.47% 10.89% 14.13% 4.52% 4.57% 7.04% 35.77% -6.75% -16.02% Cost Of Goods Sold 2,242.00 2,020.53 1,904.52 1,917.47 1,697.36 1,483.37 1,452.32 1,366.31 977.39 1,224.44 1,037.62 Gross Profit 7,618.00 7,661.91 6,628.38 5,777.73 5,044.96 4,967.20 4,716.12 4,396.17 3,267.04 3,327.01 4,381.97 GP Margin 77.26% 79.13% 77.68% 75.08% 74.83% 77.00% 76.46% 76.29% 76.97% 73.10% 80.85% Total Expenditure 6,205.00 6,106.70 5,643.73 5,230.04 4,641.60 4,258.84 4,251.45 4,149.45 3,337.05 3,424.30 2,778.67 Power & Fuel Cost - 134.25 143.43 153.21 140.00 122.04 126.70 131.49 117.86 107.17 91.17 % Of Sales - 1.39% 1.68% 1.99% 2.08% 1.89% 2.05% 2.28% 2.78% 2.35% 1.68% Employee Cost - 1,636.45 1,450.67 1,251.22 1,097.93 1,097.12 1,061.76 1,014.06 826.07 699.04 572.10 % Of Sales - 16.90% 17.00% 16.26% 16.28% 17.01% 17.21% 17.60% 19.46% 15.36% 10.56% Manufacturing Exp. - 558.41 534.71 518.96 525.94 467.64 510.53 511.80 424.29 483.38 353.59 % Of Sales - 5.77% 6.27% 6.74% 7.80% 7.25% 8.28% 8.88% 10.00% 10.62% 6.52% General & Admin Exp. - 671.08 636.24 543.33 445.93 432.42 428.65 528.34 492.53 397.46 324.98 % Of Sales - 6.93% 7.46% 7.06% 6.61% 6.70% 6.95% 9.17% 11.60% 8.73% 6.00% Selling & Distn. Exp. - 1,002.56 886.54 788.92 673.65 595.84 596.66 539.39 453.50 388.99 366.53 % Of Sales - 10.35% 10.39% 10.25% 9.99% 9.24% 9.67% 9.36% 10.68% 8.55% 6.76% Miscellaneous Exp. - 83.42 87.62 56.93 60.79 60.41 74.83 58.06 45.41 123.82 366.53 % Of Sales - 0.86% 1.03% 0.74% 0.90% 0.94% 1.21% 1.01% 1.07% 2.72% 0.60% EBITDA 3,655.00 3,575.74 2,889.17 2,465.16 2,100.72 2,191.73 1,916.99 1,613.03 907.38 1,127.15 2,640.92 EBITDA Margin 37.07% 36.93% 33.86% 32.04% 31.16% 33.98% 31.08% 27.99% 21.38% 24.76% 48.73% Other Income 6.00 31.53 91.49 81.88 204.21 118.34 236.93 381.96 332.31 299.60 293.49 Interest 194.00 213.40 303.04 297.68 236.29 334.12 430.49 480.97 293.68 202.38 179.83 Depreciation 758.00 759.48 761.05 672.34 602.43 609.84 606.66 578.90 383.88 269.36 213.41 PBT 2,685.00 2,634.39 1,916.57 1,577.02 1,466.21 1,366.11 1,116.77 935.12 562.13 955.01 2,541.17 Tax 715.00 722.12 559.49 525.63 474.76 228.26 178.26 189.70 80.09 100.79 605.36 Tax Rate 26.63% 27.67% 29.19% 33.33% 32.38% 16.71% 15.96% 20.29% 14.25% 10.55% 25.78% PAT 1,970.00 1,888.06 1,357.08 1,051.39 991.45 1,137.85 938.51 745.42 482.04 854.22 1,742.99 PAT before Minority Interest 1,970.00 1,888.06 1,357.08 1,051.39 991.45 1,137.85 938.51 745.42 482.04 854.22 1,742.99 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.98% 19.50% 15.90% 13.66% 14.70% 17.64% 15.21% 12.94% 11.36% 18.77% 32.16% PAT Growth 31.07% 39.13% 29.07% 6.05% -12.87% 21.24% 25.90% 54.64% -43.57% -50.99% EPS 58.22 55.79 40.10 31.07 29.30 33.62 27.73 22.03 14.24 25.24 51.51

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 11,835.00 11,516.09 10,727.84 9,620.15 8,508.04 8,004.57 7,939.31 7,672.80 5,949.83 5,815.69 6,666.85 Net Sales Growth 7.63% 7.35% 11.51% 13.07% 6.29% 0.82% 3.47% 28.96% 2.31% -12.77% Cost Of Goods Sold 2,856.00 2,555.63 2,458.95 2,513.20 2,230.75 1,960.12 1,981.79 2,041.26 1,535.17 1,629.66 1,432.13 Gross Profit 8,979.00 8,960.46 8,268.89 7,106.95 6,277.29 6,044.45 5,957.52 5,631.54 4,414.66 4,186.03 5,234.72 GP Margin 75.87% 77.81% 77.08% 73.88% 73.78% 75.51% 75.04% 73.40% 74.20% 71.98% 78.52% Total Expenditure 7,986.00 7,811.74 7,364.25 6,796.18 6,076.77 5,524.49 5,768.95 5,696.31 4,600.58 4,438.42 3,937.05 Power & Fuel Cost - 137.34 145.20 155.28 144.19 122.94 128.19 132.46 118.77 107.98 92.59 % Of Sales - 1.19% 1.35% 1.61% 1.69% 1.54% 1.61% 1.73% 2.00% 1.86% 1.39% Employee Cost - 2,203.37 1,984.40 1,677.69 1,526.45 1,439.62 1,429.04 1,403.79 1,135.25 993.41 842.35 % Of Sales - 19.13% 18.50% 17.44% 17.94% 17.98% 18.00% 18.30% 19.08% 17.08% 12.63% Manufacturing Exp. - 594.29 570.58 570.79 591.13 550.92 544.11 558.84 457.58 502.16 353.45 % Of Sales - 5.16% 5.32% 5.93% 6.95% 6.88% 6.85% 7.28% 7.69% 8.63% 5.30% General & Admin Exp. - 960.60 980.72 775.30 637.65 633.48 801.98 763.90 677.71 578.05 637.92 % Of Sales - 8.34% 9.14% 8.06% 7.49% 7.91% 10.10% 9.96% 11.39% 9.94% 9.57% Selling & Distn. Exp. - 1,260.67 1,129.68 1,026.99 884.91 742.63 807.39 738.03 641.30 567.70 547.05 % Of Sales - 10.95% 10.53% 10.68% 10.40% 9.28% 10.17% 9.62% 10.78% 9.76% 8.21% Miscellaneous Exp. - 99.84 94.72 76.93 61.69 74.78 76.45 58.03 34.80 59.46 547.05 % Of Sales - 0.87% 0.88% 0.80% 0.73% 0.93% 0.96% 0.76% 0.58% 1.02% 0.47% EBITDA 3,849.00 3,704.35 3,363.59 2,823.97 2,431.27 2,480.08 2,170.36 1,976.49 1,349.25 1,377.27 2,729.80 EBITDA Margin 32.52% 32.17% 31.35% 29.35% 28.58% 30.98% 27.34% 25.76% 22.68% 23.68% 40.95% Other Income -38.00 39.91 61.97 63.22 196.56 56.91 121.30 63.62 298.84 223.30 228.80 Interest 233.00 252.31 353.56 333.44 255.06 352.94 450.71 503.75 308.48 205.56 183.98 Depreciation 799.00 794.93 808.27 706.59 662.16 657.79 654.38 617.69 408.60 306.92 237.55 PBT 2,755.00 2,697.02 2,263.73 1,847.16 1,710.61 1,526.26 1,186.57 918.67 931.01 1,088.09 2,537.07 Tax 753.00 761.56 695.73 601.93 448.73 274.38 161.85 125.35 252.87 154.51 610.17 Tax Rate 27.33% 28.49% 29.58% 32.59% 36.60% 17.98% 13.64% 22.32% 27.16% 14.20% 26.04% PAT 2,002.00 1,911.25 1,656.38 1,245.23 777.18 1,251.88 1,024.72 436.28 678.11 933.55 1,733.24 PAT before Minority Interest 2,002.00 1,911.25 1,656.38 1,245.23 777.18 1,251.88 1,024.72 436.31 678.14 933.58 1,733.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 -0.03 -0.03 -0.03 PAT Margin 16.92% 16.60% 15.44% 12.94% 9.13% 15.64% 12.91% 5.69% 11.40% 16.05% 26.00% PAT Growth 15.39% 15.39% 33.02% 60.22% -37.92% 22.17% 134.88% -35.66% -27.36% -46.14% EPS 59.16 56.48 48.95 36.80 22.97 36.99 30.28 12.89 20.04 27.59 51.22

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 7,592.50 6,828.76 6,455.96 6,345.42 6,030.10 5,120.97 5,015.27 4,556.49 4,453.71 3,707.31 Share Capital 169.23 169.23 169.23 84.62 84.62 84.62 84.62 84.62 84.62 84.62 Total Reserves 7,423.27 6,659.53 6,286.73 6,260.80 5,945.48 5,036.35 4,930.65 4,471.87 4,369.09 3,622.69 Non-Current Liabilities 2,269.63 2,559.23 3,006.82 2,383.78 3,116.81 3,308.26 3,924.18 4,275.21 2,442.69 2,079.28 Secured Loans 1,020.59 1,603.78 2,331.78 1,971.60 2,941.07 3,138.43 3,736.88 4,105.31 2,197.48 1,773.65 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 1.56 3.11 6.15 11.26 10.62 Long Term Provisions 337.78 282.15 244.54 210.83 193.93 176.72 163.77 149.10 126.34 114.69 Current Liabilities 2,979.63 2,988.60 3,409.15 2,423.36 2,585.80 3,387.48 3,087.82 2,987.55 1,154.51 1,501.95 Trade Payables 767.11 759.76 610.63 624.21 648.05 682.07 582.33 775.72 547.95 665.17 Other Current Liabilities 990.51 827.90 1,450.12 1,278.84 1,420.54 1,822.33 1,694.82 1,091.57 551.16 789.83 Short Term Borrowings 941.88 1,200.00 1,197.77 399.97 410.38 789.31 726.60 1,040.20 0.00 0.00 Short Term Provisions 280.13 200.94 150.63 120.34 106.83 93.77 84.07 80.06 55.40 46.95 Total Liabilities 12,841.76 12,376.59 12,871.93 11,152.56 11,732.71 11,816.71 12,027.27 11,819.25 8,050.91 7,288.54 Net Block 7,554.04 7,985.92 7,971.85 6,251.25 6,741.24 7,197.50 7,425.15 7,428.53 3,523.49 2,681.39 Gross Block 13,300.97 12,999.81 12,366.86 10,002.35 9,952.74 9,805.61 9,465.64 8,905.10 4,634.19 3,531.56 Accumulated Depreciation 5,746.93 5,013.89 4,395.01 3,751.10 3,211.50 2,608.11 2,040.49 1,476.57 1,110.70 850.17 Non Current Assets 8,492.96 8,635.53 8,944.85 7,092.51 7,590.83 7,997.45 8,278.32 8,180.11 4,505.33 4,150.74 Capital Work in Progress 401.84 226.23 697.93 567.50 588.11 536.41 497.58 447.38 473.07 983.69 Non Current Investment 410.52 322.27 205.12 183.66 174.87 134.87 134.87 149.83 148.41 153.91 Long Term Loans & Adv. 121.45 95.24 68.42 65.30 75.61 100.91 93.35 93.32 237.96 246.50 Other Non Current Assets 5.11 5.87 1.53 24.80 11.00 27.76 127.37 61.05 122.40 85.25 Current Assets 4,348.80 3,741.06 3,927.08 3,933.40 4,141.88 3,819.26 3,748.95 3,639.14 3,545.58 3,137.80 Current Investments 112.21 141.04 156.09 183.98 139.05 0.02 351.35 475.22 787.43 764.24 Inventories 1,560.83 1,565.59 1,602.23 1,797.11 1,911.74 1,507.76 1,358.30 1,299.40 1,032.29 970.13 Sundry Debtors 2,170.79 1,571.94 1,729.44 1,541.35 1,544.26 1,508.94 1,356.01 1,108.04 1,018.47 911.50 Cash & Bank 109.74 108.76 147.61 69.46 66.42 390.95 237.84 57.09 78.22 82.37 Other Current Assets 395.23 231.24 156.52 232.90 480.41 411.59 445.45 699.39 629.17 409.56 Short Term Loans & Adv. 164.19 122.49 135.19 108.60 41.24 62.74 86.19 182.76 110.06 119.86 Net Current Assets 1,369.17 752.46 517.93 1,510.04 1,556.08 431.78 661.13 651.59 2,391.07 1,635.85 Total Assets 12,841.76 12,376.59 12,871.93 11,025.91 11,732.71 11,816.71 12,027.27 11,819.25 8,050.91 7,288.54

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 7,590.69 6,856.15 6,198.07 5,952.95 5,837.17 4,823.22 4,724.35 4,622.19 4,350.13 3,494.10 Share Capital 169.23 169.23 169.23 84.62 84.62 84.62 84.62 84.62 84.62 84.62 Total Reserves 7,421.46 6,686.92 6,028.84 5,868.33 5,752.55 4,738.60 4,639.73 4,537.57 4,265.51 3,409.48 Non-Current Liabilities 2,087.71 2,224.05 2,822.81 2,238.15 2,924.20 3,299.15 3,861.40 4,142.42 2,303.33 1,994.65 Secured Loans 1,191.75 1,603.78 2,496.22 2,123.22 2,941.07 3,302.29 3,909.81 4,105.31 2,229.57 1,839.46 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 1.56 3.11 6.15 11.26 10.62 Long Term Provisions 501.27 444.69 393.06 368.74 369.62 338.34 288.52 286.66 263.04 246.36 Current Liabilities 4,717.19 5,425.25 5,447.30 4,415.09 4,891.62 5,454.16 5,165.32 5,202.17 2,738.26 3,285.48 Trade Payables 1,820.02 2,089.32 1,678.80 1,674.44 2,066.81 2,048.81 2,096.74 2,048.24 1,749.32 2,260.22 Other Current Liabilities 1,143.50 1,130.15 1,578.41 1,365.10 1,635.36 1,860.80 1,641.26 1,151.68 687.14 822.28 Short Term Borrowings 1,249.97 1,637.71 1,765.07 923.04 704.40 1,090.85 934.11 1,625.60 0.00 3.32 Short Term Provisions 503.70 568.07 425.02 452.51 485.05 453.70 493.21 376.65 301.80 199.66 Total Liabilities 14,395.59 14,505.45 14,468.18 12,606.19 13,652.99 13,576.53 13,751.07 13,967.30 9,392.21 8,774.69 Net Block 7,946.90 8,138.11 8,121.45 6,422.65 7,064.63 7,533.12 7,747.71 7,854.68 3,688.44 2,859.08 Gross Block 14,041.34 13,484.57 12,811.62 10,728.19 10,511.53 10,334.13 9,935.43 9,449.48 4,909.80 3,793.53 Accumulated Depreciation 6,094.44 5,346.46 4,690.17 4,305.54 3,446.90 2,801.01 2,187.72 1,594.80 1,221.36 934.45 Non Current Assets 8,773.02 8,893.97 9,139.00 7,311.54 8,129.77 8,595.61 8,713.53 8,704.89 4,512.74 4,085.66 Capital Work in Progress 478.14 360.51 765.40 629.82 889.38 711.93 617.12 646.94 519.49 1,041.58 Non Current Investment 43.57 31.80 42.70 42.33 42.09 2.09 2.09 0.09 0.09 0.09 Long Term Loans & Adv. 294.29 349.34 181.04 166.55 96.84 222.19 150.58 130.96 182.32 99.66 Other Non Current Assets 10.12 14.21 28.41 50.19 36.83 126.28 196.03 72.22 122.40 85.25 Current Assets 5,622.57 5,611.48 5,313.72 5,164.99 5,523.22 4,980.92 5,037.54 5,262.41 4,879.47 4,689.03 Current Investments 112.21 141.04 156.09 183.98 139.05 0.02 351.35 492.27 803.55 779.59 Inventories 2,541.25 2,279.07 2,229.64 2,462.32 2,681.20 2,148.22 1,935.15 1,966.30 1,559.15 1,357.98 Sundry Debtors 1,866.45 1,844.30 1,943.82 1,632.48 1,523.37 1,649.34 1,435.71 1,253.45 950.89 1,445.09 Cash & Bank 579.46 839.04 571.46 403.41 603.50 666.65 816.04 867.23 893.72 647.03 Other Current Assets 523.20 327.99 246.89 331.62 576.10 516.69 499.29 683.16 672.16 459.34 Short Term Loans & Adv. 199.58 180.04 165.82 151.18 63.41 73.48 93.46 95.39 82.62 90.18 Net Current Assets 905.38 186.23 -133.58 749.90 631.60 -473.24 -127.78 60.24 2,141.21 1,403.55 Total Assets 14,395.59 14,505.45 14,452.72 12,476.53 13,652.99 13,576.53 13,751.07 13,967.30 9,392.21 8,774.69

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 2,574.50 2,893.10 2,265.41 2,140.10 1,572.89 1,579.90 1,231.83 929.14 679.38 2,403.00 PBT 2,610.18 1,916.57 1,577.02 1,466.21 1,366.11 1,116.77 935.12 562.13 955.01 2,348.35 Adjustment 969.50 957.61 990.49 827.91 884.80 857.08 820.78 622.51 369.49 480.67 Changes in Working Capital -515.07 343.60 -29.64 86.25 -468.12 -187.25 -315.89 -123.22 -389.94 63.75 Cash after chg. in Working capital 3,064.61 3,217.78 2,537.87 2,380.37 1,782.79 1,786.60 1,440.01 1,061.42 934.56 2,892.77 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -490.11 -324.68 -272.46 -240.27 -209.90 -206.70 -208.18 -132.28 -255.18 -489.77 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -470.09 -296.07 -2,384.07 -159.70 -316.28 269.43 -373.33 -4,206.99 -532.60 -586.20 Net Fixed Assets -476.77 -161.25 -2,494.94 -29.00 -198.83 -378.80 -610.74 -4,245.22 -592.01 -471.42 Net Investments -59.42 -102.10 6.43 -53.72 -179.03 351.33 138.83 310.79 -17.69 -484.32 Others 66.10 -32.72 104.44 -76.98 61.58 296.90 98.58 -272.56 77.10 369.54 Cash from Financing Activity -2,104.46 -2,577.57 80.74 -1,977.27 -1,581.20 -1,555.48 -927.58 2,928.72 -131.25 -1,325.82 Net Cash Inflow / Outflow -0.05 19.46 -37.92 3.13 -324.59 293.85 -69.08 -349.13 15.53 490.98 Opening Cash & Equivalents 104.86 85.40 65.00 61.87 386.46 92.61 512.99 862.12 846.59 353.83 Closing Cash & Equivalent 104.81 104.86 85.40 65.00 61.87 386.46 443.91 512.99 862.12 846.59

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 2,585.11 3,266.08 2,368.13 1,802.99 2,005.35 1,392.91 1,798.08 894.15 1,008.84 2,742.12 PBT 2,672.81 2,352.11 1,847.16 1,225.91 1,526.26 1,186.57 561.66 931.01 1,088.09 2,343.44 Adjustment 996.05 993.99 937.24 1,349.95 992.84 876.21 1,418.19 606.92 430.27 552.44 Changes in Working Capital -480.93 418.08 -18.20 -351.85 -338.25 -385.83 99.39 -360.16 -125.21 423.58 Cash after chg. in Working capital 3,187.93 3,764.18 2,766.20 2,224.01 2,180.85 1,676.95 2,079.24 1,177.77 1,393.15 3,319.46 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -602.82 -498.10 -398.07 -421.02 -175.50 -284.04 -281.16 -283.62 -384.31 -577.34 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -540.05 -167.90 -2,415.31 -196.63 -449.42 198.61 -241.28 -4,706.95 -786.91 -837.85 Net Fixed Assets -476.77 -161.25 -2,494.94 -29.00 -198.83 -378.80 -610.74 -4,245.22 -592.01 -471.42 Net Investments -59.42 -102.10 6.43 -53.72 -179.03 351.33 138.83 310.79 -17.69 -484.32 Others -3.86 95.45 73.20 -113.91 -71.56 226.08 230.63 -772.52 -177.21 117.89 Cash from Financing Activity -2,297.99 -2,779.64 77.36 -1,781.05 -1,650.79 -1,549.04 -1,314.45 3,417.39 -192.91 -1,435.15 Net Cash Inflow / Outflow -252.93 318.54 30.18 -174.69 -94.86 42.48 242.35 -395.41 29.02 469.12 Opening Cash & Equivalents 835.14 508.53 398.40 572.56 661.82 588.76 702.04 1,067.57 1,049.86 612.38 Closing Cash & Equivalent 573.48 835.14 508.53 398.40 572.56 661.82 940.06 702.04 1,067.57 1,049.86

Financial Ratios

Consolidated /

Standalone

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 224.32 201.76 190.75 187.47 178.15 302.59 296.34 269.23 263.16 219.06 ROA 14.97% 10.75% 8.75% 8.66% 9.66% 7.87% 6.25% 4.85% 11.14% 25.29% ROE 26.18% 20.43% 16.43% 16.02% 20.41% 18.52% 15.58% 10.70% 20.93% 54.36% ROCE 27.82% 20.96% 18.10% 16.94% 16.30% 14.68% 13.46% 9.89% 18.01% 45.21% Fixed Asset Turnover 0.75 0.69 0.70 0.69 0.66 0.65 0.63 0.64 1.12 1.57 Receivable days 69.04 69.19 76.09 82.04 85.05 83.57 77.19 90.16 76.69 70.22 Inventory Days 57.67 66.39 79.08 98.61 95.25 83.60 83.26 98.86 79.57 58.76 Payable days 137.91 131.32 117.53 136.79 163.65 52.42 59.32 72.18 69.01 88.12 Cash Conversion Cycle -11.21 4.26 37.63 43.85 16.66 114.75 101.13 116.84 87.25 40.85 Total Debt/Equity 0.34 0.49 0.71 0.53 0.73 1.04 1.12 1.28 0.55 0.61 Interest Cover 13.23 7.32 6.30 7.21 5.09 3.59 2.94 2.91 5.72 14.06

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 224.27 202.57 183.13 175.87 172.45 284.99 279.15 273.11 257.04 206.46 ROA 13.23% 11.43% 9.20% 5.92% 9.20% 7.50% 3.15% 5.81% 10.28% 20.89% ROE 26.46% 25.38% 20.50% 13.18% 23.49% 21.47% 9.34% 15.12% 23.80% 57.92% ROCE 27.32% 24.28% 20.32% 14.35% 17.62% 15.28% 9.75% 13.81% 20.36% 45.63% Fixed Asset Turnover 1.22 1.27 1.39 1.43 1.43 1.48 1.50 1.57 1.35 1.82 Receivable days 40.18 41.38 39.99 37.86 38.92 37.65 33.78 35.74 74.66 82.76 Inventory Days 52.20 49.26 52.47 61.71 59.24 49.84 49.01 57.16 90.90 66.19 Payable days 279.17 279.66 243.50 306.08 383.19 133.47 139.05 150.99 171.27 204.35 Cash Conversion Cycle -186.79 -189.03 -151.04 -206.50 -285.04 -45.98 -56.26 -58.09 -5.72 -55.41 Total Debt/Equity 0.40 0.57 0.85 0.68 0.83 1.21 1.28 1.40 0.58 0.67 Interest Cover 11.59 7.65 6.54 5.81 5.32 3.63 2.11 4.02 6.29 13.74

Top Investors:

nps trust

investor education and protection fund (iepf)

Annual Reports:

News Update:

Torrent Pharmaceuticals reports 20% rise in Q1 consolidated net profit
28th Jul 2025, 16:59 PM

The total consolidated income of the company increased by 8.95% at Rs 3,141 crore for Q1FY26
Read More
Torrent Pharmaceuticals seeks CCI’s nod to acquire majority stake in J B Chemicals
18th Jul 2025, 14:12 PM

After the completion of the deal, Torrent Pharmaceuticals will become India's second most valued pharma company
Read More
Torrent Pharma executes SPA to acquire 2.41% stake in J.B. Chemicals & Pharmaceuticals
4th Jul 2025, 10:40 AM

The company has executed share purchase agreement with employees of the J.B. Chemicals & Pharmaceuticals
Read More
Torrent Pharmaceuticals to acquire controlling stake in JB Pharma
30th Jun 2025, 09:28 AM

The company will acquire 46.39% equity stake of JB Pharma through a SPA at a consideration of Rs 11,917 crore
Read More
Torrent Pharmaceuticals raises Rs 300 crore through Commercial Papers
27th Jun 2025, 11:30 AM

Maturity of the said Commercial Papers will be on September 26, 2025
Read More
Torrent Pharmaceuticals raises Rs 200 crore through Commercial Papers
21st Jun 2025, 11:35 AM

Tenure of the instrument is 90 days
Read More

Torrent Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

BSE: 500420 | NSE: TORNTPHARM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Torrent Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - Global

BSE: 500420 | NSE: TORNTPHARM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: